SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹-2,731 Cr | ₹-1,998 Cr | ₹-1,316 Cr | ₹-1,515 Cr | ₹246 Cr |
What is the latest Total Non-Current Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹-2,731 Cr |
Mar2023 | ₹-1,998 Cr |
Mar2022 | ₹-1,316 Cr |
Mar2021 | ₹-1,515 Cr |
Mar2020 | ₹246 Cr |
How is Total Non-Current Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-2,731 Cr | Negative | |
Mar2023 | ₹-1,998 Cr | Negative | |
Mar2022 | ₹-1,316 Cr | Negative | |
Mar2021 | ₹-1,515 Cr | Negative | |
Mar2020 | ₹246 Cr | - |
Compare Total Non-Current Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹404,893.9 Cr | -1.3% | 4.7% | 3.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹148,474.0 Cr | 1.9% | 1.5% | 41.9% | Stock Analytics | |
CIPLA | ₹118,166.0 Cr | 3.4% | 0.1% | -3.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹105,849.0 Cr | -4.8% | 1.9% | 20.3% | Stock Analytics | |
MANKIND PHARMA | ₹97,009.6 Cr | -4% | 4% | -1.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,553.6 Cr | -0.1% | -1% | -11.3% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | -1.3% |
4.7% |
3.3% |
SENSEX | -1.5% |
1.1% |
1.2% |
You may also like the below Video Courses